Overview

Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Uroxatral (alfuzosin) may not only help BPH symptoms but may also improve sexual function in males with BPH and ED.
Phase:
N/A
Details
Lead Sponsor:
University Hospitals Cleveland Medical Center
Collaborator:
Sanofi
Treatments:
Alfuzosin